Cargando…

Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562507/ https://www.ncbi.nlm.nih.gov/pubmed/34725217 http://dx.doi.org/10.1136/jitc-2021-003005corr1

Ejemplares similares

GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
por: DeNardo, David G, et al.
Publicado: (2021)

Correction to Lancet Respir Med 2021; 9: 1275–87
Publicado: (2022)

Correction: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Publicado: (2022)

Publisher Correction: Lyso-Gb3 modulates the gut microbiota and decreases butyrate production
por: Aguilera-Correa, John-Jairo, et al.
Publicado: (2020)

Correction: Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
Publicado: (2021)

Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1
Publicado: (2023)

Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL
por: Reusing, Sarah B., et al.
Publicado: (2021)

Correction to: N-glucosyltransferase GbNGT1 from ginkgo complements the auxin metabolic pathway
por: Yin, Qinggang, et al.
Publicado: (2022)

Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022)

Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease
por: Bichet, Daniel G., et al.
Publicado: (2020)

Correction: Discovery and clinical introduction of first-in-class imipridone ONC201
por: Allen, Joshua E., et al.
Publicado: (2021)

Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents
por: Velasco-de Andrés, María, et al.
Publicado: (2020)

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
por: Buqué, Aitziber, et al.
Publicado: (2020)

Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic
por: Kleideiter, Elke, et al.
Publicado: (2018)

Correction to: Aspinall S, et al. Human Vaccines and Immunotherapeutics Volume 8, Issue 8; pp.1109–18
por: Aspinall, Sanet, et al.
Publicado: (2013)

Correction: Detection and Characterization of CD133(+) Cancer Stem Cells in Human Solid Tumours
por: Tirino, Virginia, et al.
Publicado: (2008)

Author Correction: Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors
por: Brightman, Spencer E., et al.
Publicado: (2023)

UV-B promotes flavonoid biosynthesis in Ginkgo biloba by inducing the GbHY5-GbMYB1-GbFLS module
por: Liu, Sian, et al.
Publicado: (2023)

Correction: Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer
por: Jia, Keren, et al.
Publicado: (2023)

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
por: Maruyama, Hiroki, et al.
Publicado: (2019)

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
por: Maruyama, Hiroki, et al.
Publicado: (2018)

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
por: Maruyama, Hiroki, et al.
Publicado: (2018)

Correction: Cultivation and genomics of the first freshwater SAR11 (LD12) isolate
por: Henson, Michael W., et al.
Publicado: (2019)

Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4(+) CTL
por: Hegde, Nagendra R., et al.
Publicado: (2005)

Author Correction: Bcl11b controls odorant receptor class choice in mice
por: Enomoto, Takayuki, et al.
Publicado: (2019)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2015)

Correction: Applying a biopsychosocial model to migraine: rationale and clinical implications
por: Rosignoli, Chiara, et al.
Publicado: (2022)

Correction to: The Italian tremor Network (TITAN): rationale, design and preliminary findings
por: Erro, Roberto, et al.
Publicado: (2022)

Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors
por: Pires, Eusebio S., et al.
Publicado: (2017)

Correction: HIV-1 Fusion Is Blocked through Binding of GB Virus C E2D Peptides to the HIV-1 gp41 Disulfide Loop
por: Eissmann, Kristin, et al.
Publicado: (2014)

Publisher Correction: Virtual Genome Walking across the 32 Gb Ambystoma mexicanum genome; assembling gene models and intronic sequence
por: Evans, Teri, et al.
Publicado: (2018)

Mesothelin: An Immunotherapeutic Target beyond Solid Tumors
por: Faust, Joshua R., et al.
Publicado: (2022)

Correction: Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
por: Theobald, Sebastian J., et al.
Publicado: (2021)

Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
por: Al‑Darraji, Ahmed, et al.
Publicado: (2021)

Correction to: Classes of tree-based networks
por: Fischer, Mareike, et al.
Publicado: (2021)

Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
por: Wang, Pengju, et al.
Publicado: (2018)

Correction: Vol. 17, No. 11
Publicado: (2011)

Correction: Vol. 16, No. 11
Publicado: (2011)

Correction, vol. 11, no. 6
Publicado: (2005)

Correction: Vol. 11, No. 10
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_9f1hda4ddsopogr09comnimjha